Image Credit: Shutterstock
TATA Medical and Diagnostics (TATA MD) has received an order for 5 lakh tests from Odisha State Medical Corporation Limited (OSMCL). The Government of Odisha is the first state in the country to order the TATA MD CHECK OmiSure RT- PCR tests developed in partnership with ICMR for detection of the Omicron variant of COVID.
TATA MD CHECK RT-PCR OmiSure is the only test approved by the ICMR for RT-PCR detection of the Omicron variant. It targets 3 gene with a single tube, fully multiplexed assay in a unique design that identifies simultaneous S-gene Target Failure (SGTF) and S-Gene Mutation Amplification (SGMA).
Girish Krishnamurthy, CEO and MD, TATA Medical and Diagnostics said, “OmiSure is the only test that can specifically detect the Omicron variant at the point of testing. We would like to thank the Government of Odisha, the first state in the country that has decided to use TATA MD OmiSure for COVID testing and would provide all necessary support.”
